Introduction
Valproic acid (VPA), a simple branched-chain fatty acid with a broad spectrum of anticonvulsant activity, is widely used in the treatment of epilepsy'. In three patients concomitantly treated with VPA and carbenin® (panipenem/ betamipron), a carbapenem antibiotic, an interesting drug reaction resulting in a decreased plasma level of VPA has been reported2~. We reported previously that this VPA-carbenin® interaction also occurs in Beagle dogs and is quite likely to be the result of the increased glucuronidation of VPA, the major clearance pathway of VPA in animals and humans3~. Therefore, synthe- 
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